Molecular Simulation Study Reveals How Propolis Compounds Cross the Blood-Brain Barrier
Researchers used all-atom molecular dynamics simulations to compare how two propolis-derived compounds, CAPE and Artepillin-C, interact with a realistic blood-brain barrier lipid bilayer model. CAPE showed a low energy barrier and favorable permeability, while Artepillin-C faced substantial resistance within the membrane core and was effectively blocked. The findings offer mechanistic insight that could guide the design of plant-derived compounds intended to treat neurological conditions.
A study posted to bioRxiv employed atomistic molecular dynamics simulations—including steered molecular dynamics and umbrella sampling—to examine how two bioactive compounds found in propolis passively permeate a compositionally realistic blood-brain barrier (BBB) lipid bilayer. Caffeic Acid Phenethyl Ester (CAPE) encountered only a modest free energy barrier (~2–3 kcal/mol) at the lipid headgroup region and minimal resistance in the hydrophobic core, yielding a favorable effective permeability (logP_eff ~ 0.28). Artepillin-C (ARC), by contrast, faced a substantial energetic barrier within the membrane interior, resulting in very poor permeability (logP_eff ~ -10.91). The heterogeneous lipid model used in the simulations reproduced experimentally consistent membrane properties, lending credibility to the computed transport energetics. The authors argue that this approach provides mechanistic detail—such as where in the membrane resistance arises—that experimental assays and machine learning models cannot easily supply. These results suggest CAPE is a more promising candidate for neurotherapeutic applications than ARC, at least with respect to passive BBB permeation. More broadly, the work demonstrates how atomistic simulation can serve as a rational screening tool in early-stage drug discovery for central nervous system targets.
What's missing
As a preprint, this work has not yet undergone peer review. The study models only passive transcellular permeation and does not account for active transport, efflux pumps (e.g., P-glycoprotein), or paracellular routes that also govern in vivo BBB penetration. The simulations were not directly validated against experimental permeability measurements for these specific compounds, and the biological activity or therapeutic efficacy of CAPE and ARC in the brain is not assessed.
What different sources said
- bioRxivCenter
Atomistic Simulation of Blood Brain Barrier Permeability of Propolis Derived Natural Compounds
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.